The product can not be sold in a country where it is illegal.
Buy MPHP-2201 for sale online from USA vendor
Specification
Product Name:
MPHP-2201
IUPAC Name:
methyl (1-(5-fluoropentyl)-1H-indole-3-carbonyl)phenylalaninate
Other Names:
MPHP-2201
Cas Number:
none
Molecular Formula:
C24H27FN2O3
Molar Mass:
400.16
Effect:
stimulant, psychedelic, cannabinoid
Purity of the substance:
99.6%
Physical properties:
powder
In Stock
Shipping:
- FREE 7 days from China
- INSURANCE option is local shipping from distributor in your country.
FREE & 3 Day Shipping
Payments: WU, MG, Bank Transfer , Pay with Bitcoin - get
10% OFF
Get FREE five samples 2 grams each for the main order.
What is MPHP-2201?
MPHP-2201 is a synthetic cannabinoid, primarily researched for its potential effects on the endocannabinoid system. It belongs to a category of compounds designed to mimic the effects of THC, the active ingredient in marijuana, but with potentially more potent effects. It is commonly found in powder form and often used as a research chemical. MPHP-2201 is not approved for human consumption and is illegal in many jurisdictions.
How does MPHP-2201 work?
MPHP-2201 interacts with the body’s CB1 and CB2 receptors, which are part of the endocannabinoid system. These receptors play a role in regulating various physiological processes, including mood, appetite, pain sensation, and memory. By binding to these receptors, MPHP-2201 can produce effects similar to other synthetic cannabinoids, which may include euphoria, relaxation, or increased energy. However, its effects can vary significantly, and there is a lack of comprehensive studies on its safety profile.
Is MPHP-2201 safe to use?
MPHP-2201 is not considered safe for human consumption. It is classified as a research chemical, and there are no approved medical uses for it. Its safety profile has not been adequately studied, and it can cause harmful side effects, including anxiety, hallucinations, and other severe mental health issues. Due to the lack of regulation and standardized dosages, using MPHP-2201 is highly risky and not recommended.
What are the possible side effects of MPHP-2201?
The side effects of MPHP-2201 can vary significantly from person to person, and its effects can be unpredictable. Some common side effects include:
-
Severe anxiety or paranoia
-
Hallucinations
-
Increased heart rate or blood pressure
-
Nausea and vomiting
-
Agitation or confusion
-
Risk of addiction
Given the drug’s lack of regulation, side effects may be more severe, and there could be long-term health risks.
Is MPHP-2201 legal?
The legality of MPHP-2201 varies by country and region. In many places, it is classified as a controlled substance, and its sale, distribution, or use is illegal. However, in some jurisdictions, it may not yet be explicitly banned, leading to gray areas in enforcement. Always check local regulations before purchasing or possessing substances like MPHP-2201.
Can MPHP-2201 be detected in drug tests?
MPHP-2201 can potentially be detected in drug tests, especially those that test for synthetic cannabinoids. Standard drug tests, however, may not be designed to detect synthetic cannabinoids specifically. Specialized tests can detect the presence of these substances, but this will depend on the test’s scope and the substance being tested for.
What should I do if I or someone else has taken MPHP-2201?
If you suspect that you or someone else has taken MPHP-2201 and is experiencing severe side effects, it is crucial to seek medical help immediately. Symptoms like intense anxiety, hallucinations, or cardiovascular distress can be dangerous. Contact emergency services or go to the nearest hospital for treatment.
How is MPHP-2201 commonly used?
MPHP-2201 is primarily used in research settings and has no medical uses. It is often sold in powder form and may be ingested, smoked, or vaporized. Because it is not intended for human consumption, its use outside of research contexts is illegal and highly unsafe. It is not recommended for recreational use under any circumstances.
What are the risks of using MPHP-2201?
The risks associated with MPHP-2201 include unpredictable psychological and physiological effects, addiction, and potential long-term health problems. Because synthetic cannabinoids like MPHP-2201 are often more potent than natural cannabis, users may experience stronger, more dangerous effects. The lack of regulation and quality control adds an additional layer of risk.
Can MPHP-2201 cause overdose?
Yes, MPHP-2201 has the potential to cause an overdose, especially due to its potency and the unknown purity of the substances sold. Overdose symptoms may include severe agitation, heart palpitations, seizures, or loss of consciousness. Immediate medical attention is required if an overdose is suspected.
Is there any medical use for MPHP-2201?
MPHP-2201 has no approved medical use. While synthetic cannabinoids like MPHP-2201 are studied for their potential therapeutic applications, MPHP-2201 itself is not intended for medical treatment. Its use is limited to research settings, and it is illegal for human consumption.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
Other Products:

